Table 4.
Parameters | Colchicine (n = 50) |
Placebo (n = 51) |
p |
---|---|---|---|
postoperative day 3 | |||
LVEF, % | 54 (52; 56) | 55 (53; 56) | 0.221 |
LVESV/BSA mL/m2 | 21.5 (17.6; 29.4) | 18.7 (16.2; 23.1) | 0.051 |
LVEDV/BSA mL/m2 | 47.7 (43.1; 57.6) | 43.8 (35.8; 52.6) | 0.032 |
Pericardial effusion, n (%) | 3 (6) | 8 (15.7) | 0.204 |
Pericardial effusion, mm | 5 (4; 5) | 5 (5; 10.8) | 0.220 |
Pericardial effusion, n (%) | 22 (44) | 16 (31.4) | 0.139 |
Pericardial effusion, mm | 19 (11; 21.5) | 19 (10; 27) | 0.811 |
postoperative day 5 | |||
LVEF, % | 55 (51; 56) | 55 (54.2; 57) | 0.098 |
LVESV/BSA mL/m2 | 21.5 (17.9; 26.6) | 18.5 (16.3; 23.9) | 0.075 |
LVEDV/BSA mL/m2 | 49.3 (42.3; 57.6) | 42.8 (37.2; 53.3) | 0.027 |
Pericardial effusion, n (%) | 8 (16) | 15 (29,4) | 0.094 |
Pericardial effusion, mm | 5.5 (4.25; 6) | 5 (4; 5.5) | 0.427 |
Pericardial effusion, n (%) | 19 (38) | 21 (41.2) | 0.809 |
Pericardial effusion, mm | 15 (11.5; 22) | 20 (12.3; 33.5) | 0.225 |
LV EF—left ventricular ejection fraction, LVESV—left ventricular end systolic volume, BSA—body surface area, LVEDV—left ventricular end diastolic volume.